The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huber, M.
Right arrow Articles by Krystal, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huber, M.
Right arrow Articles by Krystal, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2000, 165: 124-133.
Copyright © 2000 by The American Association of Immunologists

Thapsigargin-Induced Degranulation of Mast Cells Is Dependent on Transient Activation of Phosphatidylinositol-3 Kinase1

Michael Huber2, Michael R. Hughes and Gerald Krystal3

Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Thapsigargin, which elevates cytosolic calcium levels by inhibiting the sarcoplasmic/endoplasmic reticulum calcium-dependent ATPase, was tested for its ability to degranulate bone marrow-derived mast cells (BMMCs) from src homology 2-containing inositol phosphatase +/+ (SHIP+/+) and SHIP-/- mice. As was found previously with steel factor, thapsigargin stimulated far more degranulation in SHIP-/- than in SHIP+/+ BMMCs, and this was blocked with the phosphatidylinositol-3 (PI-3) kinase inhibitors, LY294002 and wortmannin. In contrast to steel factor, however, this heightened degranulation of SHIP-/- BMMCs was not due to a greater calcium influx into these cells, nor was the thapsigargin-induced calcium influx inhibited by LY294002, suggesting that the heightened thapsigargin-induced degranulation of SHIP-/- BMMCs was due to a PI-3 kinase-regulated step distinct from that regulating calcium entry. An investigation of thapsigargin-stimulated pathways in both cell types revealed that MAPK was heavily but equally phosphorylated. Interestingly, the protein kinase C inhibitor, bisindolylmaleimide (compound 3), totally blocked thapsigargin-induced degranulation in both SHIP+/+ and SHIP-/- BMMCs. As well, thapsigargin stimulated a PI-3 kinase-dependent, transient activation of protein kinase B, and this activation was far greater in SHIP-/- than in SHIP+/+ BMMCs. Consistent with this, thapsigargin was found to be a potent survival factor, following cytokine withdrawal, for both cell types and was more potent with SHIP-/- cells. These studies have both identified an additional PI-3 kinase-dependent step within the mast cell degranulation process, possibly involving 3-phosphoinositide-dependent protein kinase-1 and a diacylglycerol-independent protein kinase C isoform, and shown that the tumor-promoting activity of thapsigargin may be due to its activation of protein kinase B and subsequent promotion of cell survival.




This article has been cited by other articles:


Home page
J. Immunol.Home page
L. M. Sly, J. Kalesnikoff, V. Lam, D. Wong, C. Song, S. Omeis, K. Chan, C. W. K. Lee, R. P. Siraganian, J. Rivera, et al.
IgE-Induced Mast Cell Survival Requires the Prolonged Generation of Reactive Oxygen Species
J. Immunol., September 15, 2008; 181(6): 3850 - 3860.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Inoue, Y. Suzuki, T. Yoshimaru, and C. Ra
Nitric oxide protects mast cells from activation-induced cell death: the role of the phosphatidylinositol-3 kinase-Akt-endothelial nitric oxide synthase pathway
J. Leukoc. Biol., May 1, 2008; 83(5): 1218 - 1229.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Textor, A. H. Licht, J. P. Tuckermann, R. Jessberger, E. Razin, P. Angel, M. Schorpp-Kistner, and B. Hartenstein
JunB Is Required for IgE-Mediated Degranulation and Cytokine Release of Mast Cells
J. Immunol., November 15, 2007; 179(10): 6873 - 6880.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W.-H. Leung and S. Bolland
The Inositol 5'-Phosphatase SHIP-2 Negatively Regulates IgE-Induced Mast Cell Degranulation and Cytokine Production
J. Immunol., July 1, 2007; 179(1): 95 - 102.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
E. Lessmann, M. Leitges, and M. Huber
A redundant role for PKC-{varepsilon} in mast cell signaling and effector function
Int. Immunol., May 1, 2006; 18(5): 767 - 773.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Gimborn, E. Lessmann, S. Kuppig, G. Krystal, and M. Huber
SHIP Down-Regulates Fc{epsilon}R1-Induced Degranulation at Supraoptimal IgE or Antigen Levels
J. Immunol., January 1, 2005; 174(1): 507 - 516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yasuoka, Y. Ihara, S. Ikeda, Y. Miyahara, T. Kondo, and S. Kohno
Antiapoptotic Activity of Akt Is Down-regulated by Ca2+ in Myocardiac H9c2 Cells: EVIDENCE OF Ca2+-DEPENDENT REGULATION OF PROTEIN PHOSPHATASE 2Ac
J. Biol. Chem., December 3, 2004; 279(49): 51182 - 51192.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Kalinina, A. Agrotis, Y. Antropova, G. DiVitto, P. Kanellakis, G. Kostolias, O. Ilyinskaya, E. Tararak, and A. Bobik
Increased Expression of the DNA-Binding Cytokine HMGB1 in Human Atherosclerotic Lesions: Role of Activated Macrophages and Cytokines
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2320 - 2325.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Windmiller and J. M. Backer
Distinct Phosphoinositide 3-Kinases Mediate Mast Cell Degranulation in Response to G-protein-coupled Versus Fcepsilon RI Receptors
J. Biol. Chem., March 28, 2003; 278(14): 11874 - 11878.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Leitges, K. Gimborn, W. Elis, J. Kalesnikoff, M. R. Hughes, G. Krystal, and M. Huber
Protein Kinase C-{delta} Is a Negative Regulator of Antigen-Induced Mast Cell Degranulation
Mol. Cell. Biol., June 15, 2002; 22(12): 3970 - 3980.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Kalesnikoff, N. Baur, M. Leitges, M. R. Hughes, J. E. Damen, M. Huber, and G. Krystal
SHIP Negatively Regulates IgE + Antigen-Induced IL-6 Production in Mast Cells by Inhibiting NF-{kappa}B Activity
J. Immunol., May 1, 2002; 168(9): 4737 - 4746.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. P. Scheid, M. Huber, J. E. Damen, M. Hughes, V. Kang, P. Neilsen, G. D. Prestwich, G. Krystal, and V. Duronio
Phosphatidylinositol (3,4,5)P3 Is Essential but Not Sufficient for Protein Kinase B (PKB) Activation; Phosphatidylinositol (3,4)P2 Is Required for PKB Phosphorylation at Ser-473. STUDIES USING CELLS FROM SH2-CONTAINING INOSITOL-5-PHOSPHATASE KNOCKOUT MICE
J. Biol. Chem., March 8, 2002; 277(11): 9027 - 9035.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Rossato, A. Nogara, M. Merico, A. Ferlin, A. Garolla, and C. Foresta
Store-Operated Calcium Influx and Stimulation of Steroidogenesis in Rat Leydig Cells: Role of Ca2+-Activated K+ Channels
Endocrinology, September 1, 2001; 142(9): 3865 - 3872.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
G. H. BROUGH, S. WU, D. CIOFFI, T. M. MOORE, M. LI, N. DEAN, and T. STEVENS
Contribution of endogenously expressed Trp1 to a Ca2+-selective, store-operated Ca2+ entry pathway
FASEB J, August 1, 2001; 15(10): 1727 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. S. Manetz, C. Gonzalez-Espinosa, R. Arudchandran, S. Xirasagar, V. Tybulewicz, and J. Rivera
Vav1 Regulates Phospholipase C{gamma} Activation and Calcium Responses in Mast Cells
Mol. Cell. Biol., June 1, 2001; 21(11): 3763 - 3774.
[Abstract] [Full Text]


Home page
BloodHome page
J. E. Damen, M. D. Ware, J. Kalesnikoff, M. R. Hughes, and G. Krystal
SHIP's C-terminus is essential for its hydrolysis of PIP3 and inhibition of mast cell degranulation
Blood, March 1, 2001; 97(5): 1343 - 1351.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. Houlard, R. Arudchandran, F. Regnier-Ricard, A. Germani, S. Gisselbrecht, U. Blank, J. Rivera, and N. Varin-Blank
Vav1 Is a Component of Transcriptionally Active Complexes
J. Exp. Med., May 6, 2002; 195(9): 1115 - 1127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.